NCT06865469View on ClinicalTrials.gov

Comparing Efficacy of Intravenous Dexmedetomidine and Lidocaine on Postoperative Analgesia in Patients Undergoing Fracture Hip Surgery

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

September 1, 2026

Conditions
Fracture Hip Surgery
Interventions
DRUG

Dexmedetomidine

dexmedetomidine will be administered by i.v. infusion at 0.4 μg/kg/h

DRUG

Lidocaine Hydrochloride 2%

lidocaine hydrochloride 2% (400 mg/20 mL) 1.5 mg/kg/h by i.v. infusion.

All Listed Sponsors
lead

Assiut University

OTHER